Life-Threatening Complications of Sickle Cell Anaemia

Sickle cell anaemia is far more than a blood disorder – it is a systemic disease that can silently damage nearly every organ in the body. The root cause is always the same: abnormally shaped red blood cells that clog small blood vessels, cutting off oxygen supply to tissues and organs. Over time, and sometimes in sudden crises, this leads to a range of life-threatening complications. According to the CDC, the estimated life expectancy of those with sickle cell disease in the United States is more than 20 years shorter than average – a sobering reminder of how serious these complications truly are. Understanding each one is critical for caregivers, educators, health workers, and anyone supporting someone living with this condition.

Stroke: a risk that begins in childhood 🔗

One of the most alarming complications of sickle cell anaemia is stroke, and unlike in the general population, it can strike very young children. When sickled red blood cells block blood flow to the brain, the result can be a sudden neurological emergency. Mayo Clinic identifies the warning signs as seizures, weakness or numbness in the arms and legs, sudden speech difficulties, and loss of consciousness – all requiring immediate emergency care, as a stroke can be fatal.

The neurological risks in sickle cell disease are wide-ranging. Research published via the NIH notes that neurological complications include silent cerebral ischemia, ischemic or haemorrhagic stroke, and cerebral venous sinus thrombosis. Because sickle cell anaemia is a well-known cause of childhood stroke, the CDC recommends that children aged 2-16 with sickle cell anaemia receive annual transcranial Doppler (TCD) ultrasound screening to identify those at elevated risk before a stroke occurs.

Acute chest syndrome: a pulmonary emergency 🔗

The CDC classifies acute chest syndrome (ACS) as a life-threatening complication in people with sickle cell disease that results in lung injury, breathing difficulty, and dangerously low oxygen levels throughout the body. It occurs when sickle-shaped cells block small blood vessels in the lungs, reducing blood flow and making breathing extremely difficult.

The typical symptoms – chest pain, fever, and shortness of breath – may seem like pneumonia initially, but ACS escalates rapidly. According to StatPearls (NIH), acute chest syndrome is the most common cause of death in patients with sickle cell disease and is responsible for roughly 25% of all deaths in those with the condition – a mortality rate comparable to that of a major cardiac event. About half of all people with sickle cell disease will experience at least one episode in their lifetime, and it always demands immediate hospital treatment.

Avascular necrosis: when bones die from within 🔗

Avascular necrosis (AVN), also called osteonecrosis or bone death, occurs when the blood vessels supplying bone tissue become blocked by sickled cells, depriving the bone of the oxygen it needs to survive. Mayo Clinic explains that when bones don’t receive enough blood, the joints narrow and the bone itself can die – most commonly affecting the hip, though the shoulders and other large joints can be involved too.

The consequences are progressive and painful: joint stiffness, chronic pain, and eventually severe structural joint damage. Research in PMC notes that orthopedic surgeries for avascular necrosis are among the high-risk procedures that further elevate the likelihood of venous thromboembolism in sickle cell patients, compounding an already complex clinical picture.

Pulmonary hypertension: high blood pressure in the lungs 🔗

Pulmonary hypertension – abnormally elevated blood pressure within the lungs’ arteries – is a serious and potentially fatal complication that is more prevalent among adults with sickle cell anaemia. The lungs become increasingly strained as the disease damages pulmonary blood vessels over time. Persistent shortness of breath and fatigue are its most common symptoms, but the condition can advance quietly until it becomes life-threatening.

Mayo Clinic identifies pulmonary hypertension as a condition that can be fatal in sickle cell patients. It is part of a broader pattern of large-vessel damage driven by haemolysis and reduced nitric oxide availability – a process that Rare Disease Advisor links to cerebrovascular disease, priapism, nephropathy, and leg ulcers as well.

Organ damage and failure: the long-term toll 🔗

The cumulative effect of repeated vascular blockages is slow but relentless damage to vital organs. Every time sickled cells obstruct blood flow, the affected tissue is deprived of oxygen-rich blood. Mayo Clinic notes that this deprivation can damage nerves and organs including the kidneys, liver, and spleen – and can ultimately be fatal.

The kidney is especially vulnerable. NIH literature describes how vaso-occlusion causes ischemic changes in the renal medulla, and chronic kidney disease is a recognised long-term outcome. The liver is affected in a significant proportion of hospitalised patients – a PMC review on sickle cell hepatopathy notes that the liver is involved in about 39% of patients admitted with acute vaso-occlusive crisis, with presentations ranging from abdominal pain to acute liver failure in severe cases.

Splenic sequestration: a sudden, life-threatening crisis 🔗

Splenic sequestration occurs when large numbers of sickled red blood cells become trapped in the spleen, causing it to swell rapidly. The result is a sudden and severe drop in circulating blood volume that can send the body into circulatory collapse. Mayo Clinic describes this as potentially life-threatening, presenting with acute abdominal pain on the left side of the body.

This crisis is particularly dangerous in young children. Rare Disease Advisor explains that splenic sequestration is more common in children with the HbSS genotype, and it involves an abrupt fall in haemoglobin levels that can cause the circulatory system to collapse. Parents and caregivers of children with sickle cell anaemia are often taught to physically check the abdomen for a rapidly enlarging spleen as part of home monitoring.

Gallstones from haemolysis: a digestive complication 🔗

In sickle cell anaemia, red blood cells are continuously destroyed at an accelerated rate – a process called haemolysis. This breakdown releases haem, which the body converts into bilirubin. When bilirubin is produced faster than the liver can process it, excess bilirubin accumulates in the bile and eventually crystallises to form gallstones. Mayo Clinic confirms that high bilirubin levels resulting from red blood cell breakdown directly cause gallstone formation in sickle cell patients.

These are not ordinary cholesterol-based gallstones. A PMC review on hepatobiliary complications of sickle cell disease clarifies that the stones are typically black pigment stones composed largely of calcium bilirubinate – a direct product of elevated bilirubin excretion from chronic haemolysis. Studies show that up to 70% of patients with sickle cell anaemia will develop gallstones at some point in their lives, with onset occurring as early as 2 to 4 years of age in some children.

Priapism and deep vein thrombosis: vascular complications beyond the obvious 🔗

Priapism 🔗

Priapism – a prolonged, painful erection unrelated to sexual arousal – is a recognised complication in males with sickle cell anaemia. It occurs when sickled cells obstruct the blood vessels in the penis, trapping blood and causing sustained engorgement. Mayo Clinic notes that repeated episodes of priapism can lead to irreversible erectile dysfunction over time. It is not merely uncomfortable – it is a urological emergency that requires prompt medical intervention to prevent permanent damage.

Deep vein thrombosis and pulmonary embolism 🔗

Sickle cell disease creates a hypercoagulable state – the blood is prone to clotting abnormally. This raises the risk of deep vein thrombosis (DVT), where a clot forms in a deep vein, typically in the legs. If that clot breaks free and travels to the lungs, it becomes a pulmonary embolism (PE) – a potentially fatal event. Mayo Clinic warns that either DVT or PE can cause serious illness or even death in people with sickle cell anaemia.

A review published in PMC on VTE in sickle cell disease highlights that the condition itself is a hypercoagulable state, and that hospitalisation, orthopedic surgeries, and pregnancy all further amplify thrombotic risk. Particularly striking is that patients with sickle cell disease who develop PE are, on average, nearly 30 years younger than those in the general population who suffer the same event – underscoring how aggressively the disease accelerates vascular damage.

Pregnancy complications: elevated risks for mother and baby 🔗

Pregnancy in women with sickle cell anaemia carries substantially higher risks for both the mother and the developing child. The physiological changes of pregnancy – increased blood viscosity, heightened metabolic demand, and a natural tendency towards hypercoagulation – interact with the existing damage caused by sickle cell disease to intensify complications. A clinical review in PMC on sickle cell disease and pregnancy explains that vaso-occlusion can even occur within the placenta, leading to impaired uteroplacental circulation, chronic foetal hypoxia, and poor foetal outcomes.

Mayo Clinic documents the elevated risks clearly: women with sickle cell anaemia face a higher likelihood of high blood pressure, blood clots, miscarriage, premature birth, and babies born with low birth weight. The data from a national Medicaid study on pregnancy-related thromboembolism adds a stark dimension – pregnant women with sickle cell disease had approximately 11 times higher odds of experiencing deep vein thrombosis or pulmonary embolism compared to pregnant women without the condition. Specialised antenatal care, including preconception counselling, is essential for managing these risks effectively.

Sickle cell anaemia’s complications are interconnected, progressive, and capable of affecting every major system in the body. The same pathological mechanism – vascular blockage by sickled red blood cells – manifests differently depending on which organ or tissue is deprived of blood. Early screening, preventive treatment such as hydroxyurea therapy recommended by the NIH for children as young as 9 months, regular monitoring, and access to specialist care remain the most powerful tools available to reduce the burden of these complications.

What do you think? Given that many of these complications – such as stroke and splenic sequestration – can strike without warning even in young children, how well-equipped are schools and community health workers to recognise the early signs and respond appropriately? And considering that pregnancy significantly amplifies these risks, what kind of preconception and antenatal support should be in place for women with sickle cell anaemia in low-resource settings?

References

1. https://www.cdc.gov/sickle-cell/data/index.html
2. https://www.mayoclinic.org/diseases-conditions/sickle-cell-anemia/symptoms-causes/syc-20355876
3. https://www.ncbi.nlm.nih.gov/books/NBK526064/
4. https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
5. https://www.ncbi.nlm.nih.gov/books/NBK441872/
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC4335704/
7. https://www.rarediseaseadvisor.com/hcp-resource/sickle-cell-disease-clinical-features/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC5561431/
9. https://www.gastrores.org/index.php/Gastrores/article/view/161/212
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC6613624/
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC10592294/